Buscar

GRIFOLS, S.A.

Página 6 de 34

desde 01/07/1988 hasta 04/12/2022

    • 26/01/2018
    • 08:27
    • GRIFOLS, S.A.
    • Others on corporate transactions
    • Acquisition of 51% of the share capital in Goetech LLC (MedKeeper).
    • Número de registro: 260997
    • Hecho relevante de GRIFOLS, S.A.
    • 05/12/2017
    • 11:49
    • GRIFOLS, S.A.
    • Loans, credit lines and guarantees
    • Grifols has obtained a new long-term loan with the European Investment Bank
    • Número de registro: 259188
    • Hecho relevante de GRIFOLS, S.A.
    • 22/11/2017
    • 17:42
    • GRIFOLS, S.A.
    • Others on business performance and financial information
    • Grifols inaugurates a plant in Brazil
    • Número de registro: 258783
    • Hecho relevante de GRIFOLS, S.A.
    • 17/11/2017
    • 17:31
    • GRIFOLS, S.A.
    • R&D: new licenses, patents and registered trademarks
    • Grifols has earned approvals from the U.S. Food and Drug Administration and from the European Medicines Agency
    • Número de registro: 258667
    • Hecho relevante de GRIFOLS, S.A.
    • 16/11/2017
    • 08:25
    • GRIFOLS, S.A.
    • Information on dividends
    • Details of the interim dividend on account of 2017 profit
    • Número de registro: 258581
    • Hecho relevante de GRIFOLS, S.A.
    • Hecho relevante de GRIFOLS, S.A.
    • 02/11/2017
    • 08:24
    • GRIFOLS, S.A.
    • Information on P&L
    • Performance summary for the third quarter 2017
    • Número de registro: 258082
    • Hecho relevante de GRIFOLS, S.A.
    • 02/11/2017
    • 08:22
    • GRIFOLS, S.A.
    • Interim financial information
    • La sociedad remite información sobre los resultados del tercer trimestre de 2017
    • Número de registro: 258081
    • Información financiera intermedia de GRIFOLS, S.A.
    • 30/10/2017
    • 08:18
    • GRIFOLS, S.A.
    • Information on dividends
    • Approval of interim dividend on account of 2017 profit
    • Número de registro: 257978
    • Hecho relevante de GRIFOLS, S.A.
    • 22/09/2017
    • 08:26
    • GRIFOLS, S.A.
    • R&D: new licenses, patents and registered trademarks
    • Grifols has earned approval from the U.S. Food and Drug Administration for a liquid formulation of its alpha-1 antitrypsin as a replacement therapy to treat alpha-1 antitrypsin deficiency, a rare genetic disorder.
    • Número de registro: 256616
    • Hecho relevante de GRIFOLS, S.A.
Página 6 de 34